These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


160 related items for PubMed ID: 7749917

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Sequences of B-chain/domain 1-10/1-9 of insulin and insulin-like growth factor 1 determine their different folding behavior.
    Chen Y, You Y, Jin R, Guo ZY, Feng YM.
    Biochemistry; 2004 Jul 20; 43(28):9225-33. PubMed ID: 15248780
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Crystal structure of a "nonfoldable" insulin: impaired folding efficiency despite native activity.
    Liu M, Wan ZL, Chu YC, Aladdin H, Klaproth B, Choquette M, Hua QX, Mackin RB, Rao JS, De Meyts P, Katsoyannis PG, Arvan P, Weiss MA.
    J Biol Chem; 2009 Dec 11; 284(50):35259-72. PubMed ID: 19850922
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Aromatic anchor at an invariant hormone-receptor interface: function of insulin residue B24 with application to protein design.
    Pandyarajan V, Smith BJ, Phillips NB, Whittaker L, Cox GP, Wickramasinghe N, Menting JG, Wan ZL, Whittaker J, Ismail-Beigi F, Lawrence MC, Weiss MA.
    J Biol Chem; 2014 Dec 12; 289(50):34709-27. PubMed ID: 25305014
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Chiral mutagenesis of insulin's hidden receptor-binding surface: structure of an allo-isoleucine(A2) analogue.
    Xu B, Hua QX, Nakagawa SH, Jia W, Chu YC, Katsoyannis PG, Weiss MA.
    J Mol Biol; 2002 Feb 22; 316(3):435-41. PubMed ID: 11866509
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. High-resolution structure of an engineered biologically potent insulin monomer, B16 Tyr-->His, as determined by nuclear magnetic resonance spectroscopy.
    Ludvigsen S, Roy M, Thøgersen H, Kaarsholm NC.
    Biochemistry; 1994 Jul 05; 33(26):7998-8006. PubMed ID: 8025104
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Receptor binding redefined by a structural switch in a mutant human insulin.
    Hua QX, Shoelson SE, Kochoyan M, Weiss MA.
    Nature; 1991 Nov 21; 354(6350):238-41. PubMed ID: 1961250
    [Abstract] [Full Text] [Related]

  • 38. The in vitro oxidative folding of the insulin superfamily.
    Guo ZY, Qiao ZS, Feng YM.
    Antioxid Redox Signal; 2008 Jan 21; 10(1):127-39. PubMed ID: 18004974
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Role of disulfide bonds in the structure and activity of human insulin.
    Chang SG, Choi KD, Jang SH, Shin HC.
    Mol Cells; 2003 Dec 31; 16(3):323-30. PubMed ID: 14744022
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 8.